CD274 and malignant peripheral nerve sheath tumor: To date, 4 case reports have documented MPNSTs responding favorably to immune checkpoint inhibitors.[10–13] We report the case of an 82-year-old Asian male with metastatic MPNST, characterized by an increase in the number of CD274/PD-L1 copies.